Juan Carlos Garcia, M.D.
Gastroenterology Clinical Services Medical Director
Professor
Juan Carlos Garcia is not currently accepting new patients. For assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Specialties
Gastrointestinal Motility Disorders
Esophageal and Anorectal Motility
Biofeedback
Pudendal Nerve Latency Test
Smartpill
Evaluation and Placement of Gastric Neurostimulators
Gastroenterology and Hepatology
Internal Medicine
Department
Locations and Contact
UC Davis Midtown Ambulatory Care Center
Midtown GI Clinic
3160 Folsom Blvd
Sacramento, CA 95816
Phone: 916-734-0779
Philosophy of Care
Our practice requires a collaborative effort from patients and providers. We are here to help you.
Clinical Interests
Juan Carlos Garcia's clinical interests focus on general gastroenterology, the treatment of gastroesophageal reflux disease (GERD), gastrointestinal motility disorders, eosinophilic esophagitis, and anal intraepithelial neoplasia.
Research/Academic Interests
Dr. Garcia's research interests include gastrointestinal motility disorders, core activity and gastrointestinal motility, mucosal immune-related response, eosinophilic esophagitis, and anal intraepithelial neoplasia.
Division
Gastroenterology and Hepatology
Center/Program Affiliation
Medical School
M.D., Universidad Central de Venezuela, Caracas, Venezuela 1989
Medical School
M.D., Gastroenterology, Yale University School of Medicine, New Haven CT 1998
Internship
Internal Medicine, Hospital Jose Gregorio Hernandez, IVSS, Caracas, Venezuela 1990-1992
Internship
Internal Medicine, Hospital of St. Raphael, Yale University School of Medicine, New Haven CT 1992-1993
Residency
Internal Medicine, Hospital of St. Raphael, Yale University School of Medicine, New Haven CT 1993-1995
Fellowship
Gastroenterology, Yale University School of Medicine, New Haven CT 1995-1998
Hu Y, French SW, Chau T, Liu HX, Sheng L, Wei F, Stondell J, Garcia JC, Du Y, Bowlus CL, Wan YY. RARβ acts as both an upstream regulator and downstream effector of miR-22, which epigenetically regulates NUR77 to induce apoptosis of colon cancer cells. FASEB J. 2019 Feb;33(2):2314-2326. doi:10.1096/fj.201801390R. Epub 2018 Sep 25. PMID:30252536.
Asmuth DM, Thompson CG, Chun TW, Ma ZM, Mann S, Sainz T, Serrano-Villar S, Utay NS, Garcia JC, Troia-Cancio P, Pollard RB, Miller CJ, Landay A, Kashuba AD. Tissue Pharmacologic and Virologic Determinants of Duodenal and Rectal Gastrointestinal-Associated Lymphoid Tissue Immune Reconstitution in HIV-Infected Patients Initiating Antiretroviral Therapy. J Infect Dis. 2017 Oct 17;216(7):813-818. doi:10.1093/infdis/jix418. PMID:28968888.
Hayes TL, Asmuth DM, Critchfield JW, Knight TH, McLaughlin BE, Yotter T, McConnell DH, Garcia JC, Pollard RB, Shacklett BL. Impact of highly active antiretroviral therapy initiation on CD4(+) T-cell repopulation in duodenal and rectal mucosa. AIDS. 2013 Mar 27;27(6):867-877. doi:10.1097/QAD.0b013e32835d85b4. PMID:23262500.
Asmuth DM, Ma ZM, Albanese A, Sandler NG, Devaraj S, Knight TH, Flynn NM, Yotter T, Garcia JC, Tsuchida E, Wu TT, Douek DC, Miller CJ. Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy. AIDS. 2013 Sep 10;27(14):2207-17. doi:10.1097/QAD.0b013e328362e54c. PMID:23660579.
Shaw JM, Hunt PW, Critchfield JW, McConnell DH, Garcia JC, Pollard RB, Somsouk M, Deeks SG, Shacklett BL. Short communication: HIV+ viremic slow progressors maintain low regulatory T cell numbers in rectal mucosa but exhibit high T cell activation. AIDS Res Hum Retroviruses. 2013 Jan;29(1):172-7. doi:10.1089/AID.2012.0268. Epub 2012 Oct 16. PMID:22998457.
Shaw JM, Hunt PW, Critchfield JW, McConnell DH, Garcia JC, Pollard RB, Somsouk M, Deeks SG, Shacklett BL. Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers. J Virol. 2011 Nov;85(21):11422-34. doi:10.1128/JVI.05608-11. Epub 2011 Aug 31. PMID:21880771.